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Abstract
Background: Conjugated linoleic acid (CLA) is a collective term for isomers of octadecadienoic acid with
conjugated double-bond system. Thus, it was the objective to investigate whether milk composition and metabolic
key parameters are affected by adding CLA to the diet of dairy cows in the first four weeks of lactation.
Methods: A study was carried out with five primiparous cows fed a CLA supplemented diet compared to five
primiparous cows without CLA supplementation. CLA supplemented cows received 7.5 g CLA/day (i.e. 50% cis(c)9,
trans(t)11- and 50% t10,c12-CLA) starting two weeks before expected calving and 20 g CLA/day (i.e. 50% c9,t11-
and 50% t10,c12-CLA) throughout day 1 to 28 of lactation.
Results: The CLA supplement was insufficiently accepted by the animals: only 61.5% of the intended amount was
ingested. Fed CLA were detectable in milk fat, whereas contents of c9,t11-CLA and t10,c12-CLA in milk fat were
higher for CLA supplemented cows compared to the control group. On average over the entire treatment period,
there was a decrease of saturated fatty acids (FA) in milk fat of CLA supplemented cows, combined with a higher
content of monounsaturated and trans FA.
Our study revealed no significant effects of c9,t11- and t10,c12-CLA supplementation either on milk yield and com-
position or on metabolic key parameters in blood. Furthermore the experiment did not indicate significant effects
of c9,t11- and t10,c12-CLA-supplementation on gene expression of peroxisome proliferator-activated receptor-alpha
(PPARa), PPARg, sterol regulatory element-binding protein-1 and tumor necrosis factor-alpha in liver tissue.
Conclusions: Feeding c9,t11- and t10,c12-CLA during the first weeks after calving did not affect metabolic key
parameters of blood serum or milk composition of fresh cows. Milk fatty acid composition was changed by
feeding c9,t11- and t10,c12-CLA resulting in higher contents of these isomers in milk fat. High contents of long
chain FA in milk fat indicate that CLA supplementation during the first four weeks of lactation did not affect
massive peripheral lipomobilization.
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Within the European Union, a system with fixed milk
quotas per farm is applied, aiming to control total milk
production and avoid surplus of milk. The quota is
e x p r e s s e da sk gm i l kw i t had e f i n e dm i l kf a tc o n t e n t ,
which allows the farmer to market a higher milk volume
if milk fat content is low. Therefore, the possibilities to
decrease milk fat content have gained interest from farm-
ers. Furthermore, the dairy industry tries to enhance con-
sumers trust in dairy fat by increasing the conjugated
linoleic acid (CLA) content. Finally, the interest in CLA
in research today is to a large extent driven by a general
interest in the mechanisms of milk fat synthesis.
Extensive basic research, established predominantly by
the group of Bauman and colleagues in Cornell, has
shown that trans(t)10,cis(c)12-CLA reduces milk fat
synthesis in the alveolar epithelial cells of the mammary
gland [1] and, consequently, milk fat percentage.
Moreover, a reduction of milk fat production was con-
sidered as an option to reduce the metabolic imbalance
of transition cows. The transition period, i.e. 21 days
before calving until day 21 after calving [2], is a critical
time frame in which the animals have to cope an enor-
mous metabolic challenge due to the rapid onset of high
milk production and a reduced dry matter intake. Mana-
ging and feeding the transition cow affects health and
productivity during lactation and is the basis for eco-
nomical and sustainable milk production. To meet
energy requirements at the beginning of lactation, an
increase of energy density of the diet by adding rumen-
protected fat may be assumed. Furthermore, the energy
deficit also could be reduced if the fat content of milk is
lowered by a feed supplement.
It is hypothesized that a reduction of milk fat percen-
tage may improve the metabolic resilience of high yield-
ing dairy cows in early lactation. Thus, it was the
objective to investigate whether milk composition and
metabolic key parameters are affected by adding rumen-
protected CLA to the diet of dairy cows in the first four
weeks of lactation.
Materials and methods
Animals, treatments, and sampling
The study was performed according to strict federal and
international guidelines on animal experimentation. The
experiment was set up according to the requirements of
the Bavarian State animal welfare committee. Ten primi-
parous Brown Swiss cows were allocated to one of two
groups before calving. Cows of control group (n = 5)
were fed a lactational diet with concentrates according
to milk yield at the onset of lactation, cows of treatment
group (n = 5) were fed the same lactational diet and
concentrates. However additional CLA supplement was
fed during the first four weeks of lactation to cows of
the CLA-group. Group arrangement was based on how
well cows accepted the fat supplement. Cows that con-
sumed the fat concentrate during five successive test
days before milk stasis (56 days before expected calving
date) immediately after submission were arranged to
CLA-treatment group. Due to the well known feed
intake depression at the beginning of lactation, espe-
cially related to the mealy and powdery supplement, a
good acceptance of the supplement by each cow of
treatment group was required. The study was performed
with primiparous cows exclusively to avoid lactation
number as a confounding factor and due to the fact that
the overall effects of CLA on milk synthesis do not
depend on the lactation number [3]. All cows were
housed in free stall barns fitted with rubber mats and
fed the same basal diet (corn silage 43%, grass silage
25%, hay 32%; NEL 1.36 Mcal/kg, Table 1) during the
prepartum period, and then switched to a lactational
diet (corn silage 60%, grass silage 23%, concentrates
12%, hay 4%, and minerals 1% of wet weight; NEL 1.55
Mcal/kg, Table 1) immediately after parturition. The
basal diet, formulated on the basis of a milk yield of 22
kg/day, was delivered once daily (0700 h) and intended
to provide ad libitum intake (> 5% residual feed). If
daily milk yield exceeded 22 kg additional concentrates
were fed (0.5 kg concentrates per kg milk). Dry matter
intake could not be assessed. Water was available at all
Table 1 Ingredients and chemical composition of
lactational and basal diet
1.
Variable Lactational diet Basal diet
Ingredient, %
Corn silage 60 43
Grass silage 23 25
Hay 4 32
Concentrates
2 12 -
Mineral mix
3 1-
Chemical analysis, %
DM 45.2 52.0
CP 12.2 12.9
CF 18.6 19.2
NFC 26.4 9.92
Ether extract 3.16 3.16
NEL, Mcal/kg 1.55 1.36
1Lactational diet was fed to all cows postpartum and basal diet was fed to all
cows prepartum.
2 Composition: corn gluten 18.4%, turnips molasses chips 13.8%, wheat 10.0%,
triticale 10.0%, rape cake 10.0%, maize 8.8%, malt germ 6.0%, grain distillation
residual (ProtiGrain) 5%, rape extraction grist 5%, rumen protected rape
extraction grist 5%, palm corn cake 3.3%, soy extraction grist 2.8%, sodium
bicarbonate 1.0%, calcium bicarbonate 0.99%, plant oil (palm coconut) 0.40%.
3 The mix contained calcium 14%, sodium 10%, phosphorous 5%, magnesium 5%.
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ment including rumen-protected CLA (encapsulation
technology: spray freezed; BEWITAL GmbH & Co. KG,
Südlohn-Oeding, Germany) (Table 2). They received 7.5
g CLA/day (50% c9,t11- and 50% t10,c12-CLA) starting
two weeks before expected calving and followed by 20 g
CLA/d (50% c9,t11- and 50% t10,c12-CLA) during the
first 28 days of lactation. CLA supplement was offered
at the bunk once daily immediately after milking (0600
h) while cows were fixed in the feed fence. Refusals of
CLA were weighed and recorded.
After parturition, cows were milked twice daily (0415
and 1545 h) and milk yields were recorded at each milk-
ing until day 56. Milk samples were taken at the evening
milking. Samples were separated during milking into
sample vessels (capacity about 1 liter) controlled by milk
flow rate and total amount of milk (Metatron P21, GEA
WestfaliaSurge, Boenen, Germany). One aliquot was
stored at 4°C for a maximum of 10 days with a preser-
vative (acidiol) until analyses of milk composition. A
second aliquot was stored at -20°C until analyzed for
fatty acid composition. Milk composition was analyzed
daily during the first week of lactation and thereafter
twice a week for 7 weeks (from week 2 to week 8 post-
partum). Fatty acid (FA) composition was examined
twice a week during the first 4 weeks postpartum and
weekly during the following 4 weeks (from week 5 to
week 8 postpartum).
Jugular blood samples were collected in the morning
(0700 h) at calving and at weeks 1, 2, 4, 6, and 8 of lac-
tation. Blood serum was harvested following centrifuga-
tion (2000 × g, 15 min at 4°C) and stored in three
aliquots at -20°C until analyzed for total bilirubin (TB),
glucose, non-esterified fatty acids (NEFA) and betahy-
droxybutyrate (BHB). Liver biopsies were obtained
(Bard® MAGNUM™, Covington, USA) in the morning
(0800 h) at weeks 1, 2, 4 and 8 of lactation. Liver tissue
(approx. 100 mg) was frozen immediately in liquid
nitrogen, and stored at -80°C until analyzing for gene
expression.
Milk composition analysis
Milk protein, fat, lactose, urea and pH were analyzed by
infrared-spectrophotometr i ct e c h n i q u e( M i l k o S c a n ™
FT6000) and somatic cell count was determined by
fluorescence-optical counting system (Fossomatic™ FC)
in the laboratories of Milchprüfring Bayern e.V.,
Germany.
Milk fatty acid analysis
The FA composition of milk samples was determined
using FA methyl esters (FAME) prepared by transesteri-
fication with TSMH (trimethylsulfonium hydroxide) at
room temperature. FAMEs were analyzed using gas
chromatography (GC 6890, AgilentTechnologies, Wald-
bronn, Germany) to determine isomer distribution pat-
terns. FA were quantified by use of Chromeleon® 6.8
Chromatography Software (Dionex, USA).
Blood serum analysis
Glucose, NEFA, BHB, and TB were analyzed with an
automated clinical chemistry analyzer (ABX Pentra 400,
Horiba, Montpellier, France). The hexokinase method
was applied for glucose analysis and NEFA concentra-
tions were determined with the enzymatic reactions
(both Hoffmann La-Roche, Basel, Switzerland). BHB
measurement was performed by using an enzymatic
analysis (Sigma-Aldrich Diagnostics, Munich, Germany).
TB was analyzed via Jendrassik/Grof reaction [4]. The
clinical chemistry analyzer was calibrated and controls
assayed daily according to the manufacturer’si n s t r u c -
tions to ensure acceptable assay performance.
Gene expression
Total RNA was isolated from liver tissue samples
according to the manufacturer’s instructions of peq-
GOLD TriFast™. RNA was quantified by spectrophoto-
metry (BioPhotometer, Eppendorf, Hamburg) and
diluted in RNase-free water. Degradation of the RNA
was measured with the Agilent 2100 Bioanalyzer (Agi-
lent Technologies, Waldbronn, Germany) in connection
with the RNA 6000 Nano Assay. Gene expression was
measured by reverse transcription quantitative polymer-
ase chain reaction (RT-qPCR) (SuperScript™ III Plati-
num® SYBR® Green One PCR Kit, Invitrogen, Karlsruhe,
Germany) using the RotorGene3000 (Corbett Research,
Table 2 Ingredients of CLA supplement
1.
Variable
Ingredient, %
Soybean 52
Glucose 10
CLA 15
There of c9, t11-CLA 7.5
t10, c12-CLA 7.5
Biscuit flour 4
Wheat bran 4
Cornflakes 3.5
Magnesium phosphate 3.5
Malt sprouts 2.5
Brewer’s yeast 1.5
lactalbumin powder 0.8
Soybean oil 0.2
NEL, Mcal/kg 3.35
1 Cows received 7.5 g CLA/day (50% c9,t11- and 50% t10,c12-CLA) starting
two weeks before expected calving and followed by 20 g CLA/day (50% c9,
t11- and 50% t10,c12-CLA) during the first 28 days of lactation
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activated receptor-alpha (PPARa), PPARg, sterol regula-
tory element-binding protein-1 (SREBP1) and tumor
necrosis factor-alpha (TNFa) were designed using Pri-
mer3 online-software and synthesized by Metabion
International AG (Martinsried, Germany, Table 3). The
mean of the two housekeeping genes, histone and ubi-
quitin, was calculated for the reference index and used
for normalization. Δ quantitative Cycle (Cq)-values were
calculated as ΔCq = Cqtarget gene -m e a n C q refence genes
and ΔΔCq-values were calculated according to ΔΔCq =
ΔCqtarget gene - meanΔCqrefence genes.
Statistical analysis
Endpoints measured repeatedly (milk yield, milk compo-
sition and milk FA profile) were reduced to weekly
means before statistical analysis. Differences among
treatments (group) and comparisons between times
(week) were analyzed by repeated measures ANOVA
using Bonferroni’s t-test (Sigma-Stat v.3.00 and the
PASW Statistics 17, both SPSS Inc., Chicago, USA).
The effects of group and week were considered as
fixed effects with week of experiment as a repeated mea-
surement and with cow within dietary treatment (group)
as the subject. Orthogonal polynomial contrast was used
to describe linear, quadratic or cubic trends over time
(week by group interaction) and group effects. All data
are presented as mean ± standard deviation (SD). Means
were considered to differ significantly in case P < 0.05.
Results
The CLA supplement was insufficiently accepted by the
animals after parturition: on average, only 61.5% of the
intended amount of 20 g CLA per day (10 g c9,t11- and
10 g t10,c12-CLA) was ingested. In the first week post-
partum cows ingested 10.1 ± 7.8 g CLA per day, 11.5 ±
7 . 7gC L Aa tw e e k2p o s t p a r t u m ,1 5 . 2±6 . 4C L Aa t
week 3 postpartum and 12.4 ± 6.5 g CLA at week 4 of
lactation (50% c9,t11 and 50% t10,c12-CLA). On aver-
age, cows ingested 12.3 ± 4.7 g CLA/day during the
treatment period. Results were calculated for two time-
frames: from day 1 postpartum until day 28 postpartum
(CLA supplemented period) and from day 29 postpar-
tum until day 56 postpartum. Milk yield, milk protein,
milk fat, and urea content did not differ between the
two groups (Table 4).
Metabolic key parameters did not differ between
groups during treatment and from week 5 to week 8
(Table 5).
Absorbed CLA was detectable in milk fat during the
supplementation timeframe, resulting in a shift in the
Table 3 Sequences of PCR primers
1.
Primer Sequence (5’ ! 3’)
Histone forward ACT TGC TAC AAA AGC CGC TC
reverse ACT TGC CTC CTG CAA AGC AC
Ubiquitin forward AGA TCC AGG ATA AGG AAG GCA T
reverse GCT CCA CCT CCA GGG TGA T
PPARa forward GGA TGT CCC ATA ACG CGA TTC G
reverse TCG TGG ATG ACG AAA GGC GG
PPARg forward CTC CAA GAG TAC CAA AGT GCA ATC
reverse CCG GAA GAA ACC CTT GCA TC
SREBP1 forward CCA GCT GAC AGC TCC ATT GA
reverse TGC GCG CCA CAA GGA
TNFa forward CCA CGT TGT AGC CGA CAT C
reverse CCC TGA AGA GGA CCT GTG AG
1 Primers were designed using Primer3 online software and synthesized by
metabion international AG (Martinsried, Germany).
Table 4 Means ± SD for milk yield and milk composition during and after the treatment period
1.
Control (n = 5) CLA (n = 5)
1 - 28 DIM 29 - 56 DIM 1 - 28 DIM 29 - 56 DIM
Variable mean
5 SD mean SD mean SD mean SD
milk yield
2, kg/day 24.5 2.8 28.8 2.3 24.5 3.3 28.9 2.1
3.5% FCM
3, kg/day 30.9 5.4 34.7 5.7 30.4 2.6 33.0 3.5
milk fat
4, % 6.10 0.99 5.27 0.78 5.77 0.14 4.97 0.30
milk fat
4, kg/day 1.49 0.15 1.52 0.12 1.41 0.16 1.44 0.12
milk protein
4, % 3.81 0.12 3.31 0.13 3.82 0.15 3.42 0.13
milk protein
4, kg/day 0.93 0.09 0.95 0.07 0.94 0.09 0.99 0.08
milk lactose
4, % 4.75 0.28 5.02 0.03 4.72 0.25 4.94 0.02
milk lactose
4, kg/day 1.17 0.25 1.43 0.03 1.14 0.28 1.42 0.02
urea
4, mmol/L 6.25 1.14 5.28 1.27 5.63 1.26 5.38 0.96
1CLA supplemented timeframe: d 1 till d 28 of lactation; five primiparous cows received a special supplement including rumen-protected CLA (10 g c9,t11-CLA/
day and t10,c12-CLA/day).
2Milk yield was recorded at each milking.
3FCM was calculated like following: (fat [%] × 0.15 + 0.4) × milk yield [kg/day]
4Milk composition was analyzed once daily in the first week after parturition and twice a week from week 2 until week 8 postpartum.
5Milk yield and milk composition values were reduced to weekly means, means from wk 1 till 4 are pooled to timeframe 1 - 28 DIM, means from week 5 till 8
are pooled to timeframe 29 - 56 DIM
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the entire treatment period, there was a reduction in the
yield of saturated fatty acids in the milk fat of cows
receiving CLA, together with a higher content of mono-
unsaturated and trans FA. Contents of c9,t11-CLA were
higher in milk fat of CLA supplemented cows compared
to the control group (0.73 ± 0.04 g/100 g fat vs.0 . 6 4±
0.01 g/100 g fat). In addition, contents of t10,c12-CLA
in milk fat of CLA supplemented cows were significantly
higher compared to the control group (0.02 ± 0.01 g/
100 g fat vs. 0.00 ± 0.00 g/100 g fat, P = 0.002).
Total RNA quantity and RNA integrity number (RIN)
values were similar for cows in the control group (RNA
concentrations: 1276 ± 1016 ng/μl; RIN values: 6.5 ±
2.3) and for cows in CLA supplemented group (RNA
concentrations = 1109 ± 986 ng/μl; RIN values: 6.6 ±
1.9). mRNA levels of histone and ubiquitin were tested
for normal distribution. Constant mRNA levels of his-
tone and ubiquitin was manifested by analysis of var-
iance. ΔCq-values and ΔΔCq-values of the genes
PPARa,P P A R g,S R E B P 1a n dT N F a did not differ
between the two groups and over the weeks (Table 7).
Discussion
The transition period between late pregnancy and early
lactation is characterized by a shift in nutrient partition-
ing that requires extensive coordination of metabolism
to ensure an adequate supply of nutrients to support
milk synthesis [5]. Due to this metabolic adaptation, the
CLA supplementation in this project was designed to
start before parturition and to take place along the
whole transition period.
In the present study, CLA supplementation did not
affect milk fat content. This differs from other studies
conducted with cows during established lactation, in
which feeding rumen-protected CLA [6-9] or abomasal
infusion of CLA [10-13] or intravenous infusions of
CLA [14] resulted in a reduction of milk fat content. An
explanation for the lack of a CLA response in milk fat
during the first few weeks postpartum is unknown [8].
Our analysis indicates that c9,t11- and t10,c12-CLA
were consistently transferred to milk fat throughout the
treatment period. Contents of c9,t11- and t10,c12-CLA
in milk of CLA supplemented cows were significantly
higher compared to the c9,t11- and t10,c12-CLA con-
tent in milk of cows of the control group.
Peterson et al. [3] found that t10,c12-CLA was also
transferred to milk fat and that the milk fat content of
t10,c12-CLA are curvilinearly related to reduced milk fat
yield, according to de Veth et al.[ 1 5 ] .H o w e v e ri no u r
study we could not demonstrate such a decrease of milk
fat yield. It can be speculated that at the onset of lacta-
tion the essential cellular signaling systems are attenu-
ated such that t10,c12-CLA is unable to elicit the
coordinated reduction in the expression of genes for key
lipogenic enzymes.
Furthermore in milk of CLA supplemented cows, con-
tents of short chain (< C 10) and middle chain FA
(C 10 - C 16) were reduced and the amount of long
chain FA (> C 16) was increased. These results go in
line with previous results from studies conducted during
early and mid lactation [8,9,16,17].
Results from the present study with transition cows
are partially similar to those observed after administra-
tion of CLA to cows in established lactation. In estab-
lished lactation milk yield and milk protein content
were relatively unaffected by abomasal administration of
CLA or CLA feeding [3,11,13]. In our study CLA sup-
plementation did not affect milk yield and milk protein
content.
Bernal-Santos et al. [8] presented the first study in
which rumen-protected CLA was fed during the prepar-
tum period. Supplementation had no effect on measured
performance variables and plasma metabolites. In our
study, CLA supplementation had no effects on concen-
trations of TB, glucose, NEFA and BHB in blood serum.
Table 5 Means ± SD for blood serum metabolites
1 during and after the treatment period
2.
Control (n = 5) CLA (n = 5)
1 - 28 DIM 29 - 56 DIM 1 - 28 DIM 29 - 56 DIM
Variable mean SD mean SD mean SD mean SD
TB
3, μmol/L 7.01 4.52 3.58 0.74 4.51 0.73 3.10 0.70
Glucose, mmol/L 3.40 0.11 3.53 0.06 3.47 0.28 3.53 0.19
NEFA
4, μmol/L 483 174 165 105 378 119 152 61.1
BHB
5, mmol/L 0.54 0.14 0.22 0.08 0.49 0.28 0.39 0.04
1Jugular blood samples were collected at week 0, 1, 2, 4, 6, 8. Values from week 0, 1, 2, 4 were calculated for 1 - 28 DIM, values from week 6 and 8 were
calculated for 29 - 56 DIM.
2CLA supplemented timeframe: d 1 until d 28 of lactation; five primiparous cows received a special supplement including rumen-protected CLA (10 g c9,t11-CLA/
day and t10,c12-CLA/day).
3total bilirubin.
4non-esterified fatty acids.
5betahydroxybutyrate.
Sigl et al. Acta Veterinaria Scandinavica 2010, 52:16
http://www.actavetscand.com/content/52/1/16
Page 5 of 8Table 6 Means ± SD for fatty acid composition of milk fat from cows received c9,t11- and t10,c12-CLA and for the
control group, during treatment period
1 and post-treatment.
Control (N = 5) CLA (N = 5) P-value P-value P-value P-value
1 - 28 DIM 29 - 56 DIM 1 - 28 DIM 29 - 56 DIM Control CLA Control vs.
CLA
Control vs.
CLA
mean SD mean SD mean SD mean SD 1-28 vs. 29-
56
1-28 vs. 29-
56
1-28 29-56
Fatty acid, g/100 g fat
4:0 1.40 0.10 1.20 0.12 1.38 0.11 1.24 0.04
6:0 1.14 0.06 1.18 0.06 1.13 0.13 1.23 0.02
8:0 0.84 0.03 0.94 0.02 0.86 0.10 1.01 0.04 0.003 0.038
10:0 1.91 0.12 2.39 0.20 1.95 0.20 2.55 0.13 0.011 0.012
10:1 0.15 0.03 0.25 0.02 0.15 0.02 0.28 0.03 0.09 0.003
11:0 0.05 0.02 0.08 0.08 0.04 0.01 0.07 0.01 0.013
12:0 2.90 0.18 3.79 0.44 2.87 0.41 4.04 0.30 0.013 0.016
12:1 cis-9 0.04 0.01 0.07 0.01 0.03 0.01 0.08 0.01 0.007 0.002
iso-13:0 0.04 0.01 0.08 0.01 0.04 0.01 0.09 0.02 0.008 0.03
13:0 0.09 0.02 0.14 0.09 0.07 0.01 0.12 0.02 0.013
iso-14:0 0.09 0.03 0.11 0.04 0.08 0.00 0.10 0.02
14:0 9.14 0.42 11.35 0.45 8.84 0.39 11.27 0.37 0.001 0.001
14:1 cis-9 0.57 0.08 0.86 0.13 0.57 0.05 0.88 0.13 0.013 0.0021
iso-15:0 0.10 0.00 0.11 0.00 0.09 0.01 0.10 0.01 0.012
anteiso-15:0 0.27 0.04 0.36 0.04 0.26 0.03 0.36 0.04 0.034 0.023
15:0 0.85 0.10 1.15 0.48 0.70 0.09 1.01 0.07 0.01
iso-16:0 0.23 0.03 0.23 0.07 0.21 0.02 0.22 0.01
16:0 26.17 0.82 27.90 0.95 25.74 1.57 26.62 0.95 0.05
16:1 trans-9 0.17 0.00 0.17 0.01 0.17 0.01 0.16 0.01 0.04
16:1 cis-9 1.48 0.04 1.40 0.06 1.65 0.12 1.38 0.13
iso-17:0 0.36 0.02 0.42 0.04 0.36 0.04 0.43 0.03
anteiso-17:0 0.43 0.04 0.45 0.04 0.42 0.05 0.44 0.04
17:0 0.71 0.05 0.63 0.11 0.64 0.06 0.58 0.01
17:1 cis-9 0.32 0.02 0.27 0.02 0.34 0.04 0.24 0.02 0.014 0.016
iso-18:0 0.09 0.01 0.07 0.01 0.09 0.01 0.06 0.00 0.011
18:0 11.84 0.44 9.52 0.46 11.59 0.54 10.13 0.29 0.001 0.014
18:1 trans-9 0.59 0.12 0.61 0.03 0.63 0.03 0.66 0.05
18:1 trans-10 0.30 0.02 0.36 0.05 0.31 0.05 0.39 0.05
18:1 trans-11 1.48 0.43 1.29 0.13 1.49 0.11 1.29 0.08
18:1 cis-9 25.78 1.26 22.19 0.94 26.45 1.48 22.44 0.17 0.009 0.01
18:1 cis-11 1.09 0.06 1.01 0.17 1.10 0.11 1.00 0.04
18:1 cis-12 0.24 0.04 0.27 0.02 0.27 0.05 0.28 0.02
18:1 cis-13 0.11 0.02 0.07 0.01 0.11 0.05 0.08 0.03 0.03
18:2 trans-9, trans-12 1.83 0.08 1.82 0.10 2.11 0.20 1.97 0.13 0.048
18:2 cis-9, trans-11 0.64 0.10 0.69 0.05 0.73 0.04 0.68 0.07
18:2 trans-10, cis-12 0.00 0.00 0.00 0.00 0.02 0.01 0.00 0.00 0.008 0.002
18:2 trans-9, trans-11 0.02 0.01 0.01 0.00 0.03 0.00 0.01 0.00 0.002
18:3 cis-9, cis-12, cis-15 0.43 0.03 0.40 0.06 0.43 0.01 0.36 0.01 0.003
19:0 0.06 0.00 0.05 0.00 0.04 0.01 0.05 0.01 0.015
20:0 0.14 0.01 0.13 0.00 0.13 0.00 0.14 0.00 0.004 0.029 0.027
20:1 cis-11 0.11 0.00 0.11 0.02 0.10 0.01 0.10 0.02
20:2 cis-11, cis-14 0.03 0.01 0.03 0.01 0.05 0.01 0.05 0.03
21:0 0.02 0.00 0.02 0.00 0.01 0.00 0.02 0.00 0.026 0.004
20:3 cis-8, cis-11, cis-14 0.08 0.01 0.11 0.01 0.10 0.01 0.13 0.00 0.014 0.008
20:4 cis-5, cis-8, cis-11, cis-14 0.13 0.03 0.12 0.01 0.11 0.01 0.10 0.02
22:0 0.03 0.01 0.03 0.00 0.02 0.00 0.03 0.00 0.01
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situation could not be improved by feeding CLA. Com-
parable results were obtained by Perfield et al.[ 7 ] .I n
addition, CLA supplementation had no effects on hepa-
tic mRNA levels of PPARa, PPARg, SREBP1 and TNFa.
Comparable studies, in which effects of CLA supple-
mentation on hepatic gene expression in dairy cows
were measured, do not exist to our knowledge. Previous
studies in rodents revealed effects of c9,t11- and t10,
c12-CLA on gene expression of fatty acid synthesis, fatty
acid oxidation and drug detoxification-associated
enzymes in liver tissue [18-20].
Our results go in line with previous results stating that
t10,c12-CLA affects primarily the de novo synthesis of
FA in the alveolar epithelial cells of the mammary gland
but does not inhibit peripheral lipomobilization. The
transition period is associated with an increased mobili-
zation of body fat reserves, which results in an increased
mammary uptake of circulating NEFA and their use to
synthesize milk fat triglycerides [13]. This is one expla-
nation of the considerably higher fat percentage of
bovine milk in the first weeks of lactation when precur-
sors for milk synthesis are not completely available from
feed [1].
Obviously, during the first weeks of lactation, the milk
fat depressing effects of t10,c12-CLA intake are less pro-
nounced compared to mid or late lactation. This may be
explained by a low contribution of long-chain FAs origi-
nating from lipomobilization to milk fat in mid lactation
while the proportion of t10,c12-CLA-dependend de novo
synthesized FAs is high compared to the first weeks of
lactation. The study did not provide evidence that CLA
Table 7 ΔCq
1-values (mean ± SD) of hepatic mRNA expression of the genes PPARa
2, PPARg
3, SREBP1
4, TNFa
5in CLA
supplemented cows vs. control group before (week -1), during (week 2 and 4) and after (week 8) treatment
6.
Control (n = 5) CLA (n = 5)
week -1 week 2 week 4 week 8 week -1 week 2 week 4 week 8
mean SD mean SD mean SD mean SD mean SD mean SD mean SD mean SD
ΔPPARa 1.5 0.3 1.4 0.2 1.9 0.3 1.7 0.5 2.0 0.1 1.4 0.3 1.9 0.7 2.0 0.5
ΔPPARg 7.8 0.8 9.6 2.3 9.8 2.4 9.4 0.8 9.1 0.3 8.6 0.2 9.2 0.7 9.2 0.2
ΔSREBP1 2.3 1.6 4.0 2.9 4.0 1.8 4.2 1.6 3.0 0.2 3.7 0.7 4.1 1.2 3.1 0.5
ΔTNFa 9.3 0.6 8.9 0.4 9.4 0.7 9.4 1.2 8.5 0.4 8.0 1.1 8.5 1.5 8.4 0.4
1 ΔCq-values were calculated as ΔCq = Cqtarget gene - meanCqrefence genes
2 peroxisome proliferator-activated receptor-alpha.
3peroxisome proliferator-activated receptor-gamma.
4sterol regulatory element-binding protein-1.
5tumor necrosis factor-alpha.
6CLA supplemented timeframe: day 1 till day 28 of lactation; five primiparous cows received a special supplement including rumen-protected CLA (10 g c9,t11-
CLA/day and t10,c12-CLA/day).
Table 6: Means ± SD for fatty acid composition of milk fat from cows received c9,t11- and t10,c12-CLA and for the
control group, during treatment period
1 and post-treatment. (Continued)
20:5 cis-5. cis-8, cis-11, cis-14,
cis-17
0.03 0.01 0.02 0.00 0.02 0.00 0.02 0.00 0.036
24:0 0.03 0.01 0.02 0.00 0.01 0.00 0.02 0.01 0.005
22:5 cis-7, cis-10, cis-13, cis-
16, cis-19
0.12 0.02 0.10 0.01 0.09 0.01 0.08 0.01
Other 5.36 5.43 5.35 5.44
Summation, g/100 g fat
SFA
2 58.9 0.87 62.3 1.01 57.5 1.95 61.9 0.07 0.005 0.018
MUFA
3 29.9 1.23 26.5 0.87 30.8 1.67 26.7 0.27 0.01 0.014
PUFA
4 0.39 0.06 0.38 0.03 0.39 0.01 0.38 0.03
tFA
5 4.37 0.58 4.25 0.17 4.71 0.34 4.46 0.21
CLA
6 1.12 0.07 1.14 0.10 1.20 0.05 1.08 0.06 0.046
1CLA supplemented timeframe: d 1 till d 28 of lactation; five primiparous cows received a special supplement including rumen-protected CLA (10 g c9,t11-CLA/
day and t10,c12-CLA/day). Post-treatment timeframe: 29 - 56 DIM.
2saturated fatty acids
3monounsaturated fatty acids
4polyunsaturated fatty acids
5trans fatty acids
6conjugated linoleic acids
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Page 7 of 8affected substrate partitioning in the body of the cows
which may be explained by the comparatively small
amounts fed compared to rodent studies.
The present study is the first describing supplemen-
tion of primiparous cows with CLA during the first four
weeks of lactation. However, due to the limited number
of animals per treatment group, the small amount of
supplemented CLA and the restricted supplementation
period during early lactation, it is difficult to make any
definitive conclusions about the metabolic benefits of
CLA supplementation.
Conclusions
Supplementation of c9,t11- and t10,c12-CLA during the
first four weeks of lactation resulted in an increase of
these specific CLA isomers provided during treatment.
Therefore all the CLA isomers were taken up by the
mammary gland and incorporated into milk fat. During
the first four weeks of lactation, however, CLA supple-
mentation did not affect milk yield, milk composition,
blood serum metabolites and gene expression in liver of
primiparous cows.
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